Verified Nov 2026
Other
·

Marlborough, Massachusetts
·
Since 2010
Sunovion Pharmaceuticals is a biopharmaceutical company headquartered in Marlborough, Massachusetts, founded in 1984 and employing 500-1,000 staff. It develops and commercializes therapeutic products across psychiatry, neurology, respiratory disorders, women's health, urology, oncology, and rare diseases. Owned by Sumitomo Pharma since 2009, the company serves medical institutions and healthcare providers with treatments including medications for overactive bladder, schizophrenia, and bipolar depression.
Sunovion Pharmaceuticals at a glance
Employees
500-1,000
Founded
2010
Headquarters
Marlborough, Massachusetts
Industries
Automotive
Electric Vehicles
Medical
Overview
Sunovion Pharmaceuticals is a biopharmaceutical company headquartered in Marlborough, Massachusetts, founded in 1984 and employing 500-1,000 staff. It develops and commercializes therapeutic products across psychiatry, neurology, respiratory disorders, women's health, urology, oncology, and rare diseases. Owned by Sumitomo Pharma since 2009, the company serves medical institutions and healthcare providers with treatments including medications for overactive bladder, schizophrenia, and bipolar depression.
At a glance
Attribute | Detail |
|---|---|
Founded | 2010 |
Headquarters | Marlborough, Massachusetts |
Employees | 500-1,000 |
What Sunovion Pharmaceuticals makes
The company maintains a portfolio encompassing central nervous system treatments, respiratory therapies, and rare disease solutions with a patient-centric delivery model.
Latest developments
2026-05-27 — Generalized Anxiety DisorderMarket: Growth Momentum Across 7MM To 2034 – DelveInsight | VistaGen Therapeutics, Fabre-Kramer Pharm, Mind Med, Sunovion, ChemRar Research, Biohaven Pharma, Forest Lab | PressReleaseCC (pressreleasecc.com)
2025-07-25 — Sunovion (wikipedia.org)
2025-04-08 — Sunovion Pharmaceuticals Inc. - Page 1 | BioWorld (bioworld.com)
Company details
Sunovion operates as a subsidiary of Sumitomo Pharma America, Inc. as of July 2023, with therapeutic focus spanning psychiatry, neurology, and multiple disease categories. Sunovion Pharmaceuticals was founded in 2010, has an estimated 500-1,000 employees, and is headquartered in Marlborough, Massachusetts.
Frequently asked questions
What does Sunovion Pharmaceuticals do?
Sunovion Pharmaceuticals is a biopharmaceutical company headquartered in Marlborough, Massachusetts, founded in 1984 and employing 500-1,000 staff. It develops and commercializes therapeutic products across psychiatry, neurology, respiratory disorders, women's health, urology, oncology, and rare diseases. Owned by Sumitomo Pharma since 2009, the company serves medical institutions and healthcare providers with treatments including medications for overactive bladder, schizophrenia, and bipolar depression.
Where is Sunovion Pharmaceuticals headquartered?
Sunovion Pharmaceuticals is headquartered in Marlborough, Massachusetts (84 Waterford Drive, Marlborough, Massachusetts, 01752).
When was Sunovion Pharmaceuticals founded?
Sunovion Pharmaceuticals was founded in 2010.
How big is Sunovion Pharmaceuticals?
Sunovion Pharmaceuticals has an estimated 500-1,000 employees.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
